Cancer - Genentech, Inc.

Cancer

Status:

Active, open to accrual

ClinicalTrials.gov:

NCT05800665

A PHASE I, OPEN-LABEL, MULTICENTER, DOSE-ESCALATION AND EXPANSION STUDY EVALUATING THE SAFETY, PHARMACOKINETICS, AND ACTIVITY OF RO7656594 IN PATIENTS WITH ADVANCED OR METASTATIC PROSTATE CANCER

Drug

RO7656594

Condition

Prostate Cancer